rubrofusarin B has been researched along with fonsecin in 1 studies
| Studies (rubrofusarin B) | Trials (rubrofusarin B) | Recent Studies (post-2010) (rubrofusarin B) | Studies (fonsecin) | Trials (fonsecin) | Recent Studies (post-2010) (fonsecin) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 6 | 0 | 1 |
| Protein | Taxonomy | rubrofusarin B (IC50) | fonsecin (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 38.14 | |
| Female germline-specific tumor suppressor gld-1 | Caenorhabditis elegans | 2.957 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, W; Lin, X; Liu, S; Liu, Y; Tan, S; Xun, T; Yang, B; Zhou, X | 1 |
1 other study(ies) available for rubrofusarin B and fonsecin
| Article | Year |
|---|---|
Aspernigrins with anti-HIV-1 activities from the marine-derived fungus Aspergillus niger SCSIO Jcsw6F30.
Topics: Anti-HIV Agents; Aspergillus niger; Cell Line; Drug Screening Assays, Antitumor; HIV Infections; HIV-1; Humans; Niacinamide; Pyridones | 2016 |